Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs
about
Managing pulmonary nontuberculous mycobacterial infection. time for a patient-centered approach.Management of pulmonary nontuberculous mycobacterial disease.An oxidative environment promotes growth of Mycobacterium abscessus.Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients.Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005-2011Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.Mycobacterium abscessus morphotype comparison in a murine model.Hospital costs in the US for pulmonary mycobacterial diseases.Lung manifestations in an autopsy-based series of pulmonary or disseminated nontuberculous mycobacterial diseaseMycobacterium abscessus-Induced Granuloma Formation Is Strictly Dependent on TNF Signaling and Neutrophil Trafficking.The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United StatesDirect healthcare costs of selected diseases primarily or partially transmitted by water.The Challenge of Pulmonary Nontuberculous Mycobacterial Infection.Opinions differ by expertise in Mycobacterium avium complex disease.Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosisMycobacterium abscessus: a new antibiotic nightmare.Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease.Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.Evaluation of the inflammatory response in macrophages stimulated with exosomes secreted by Mycobacterium avium-infected macrophages.Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward.High levels of intrinsic tetracycline resistance in Mycobacterium abscessus is conferred by a tetracycline- modifying monooxygenase.Nontuberculous Mycobacteria in Cystic Fibrosis.Hospital-based antibiotic use in patients with complexThe cost of Mycobacterium avium complex lung disease in Canada, France, Germany, and the United Kingdom: a nationally representative observational study
P2860
Q27693348-9FF38869-4083-49FF-891F-625DE3BC9C5DQ34167455-1ECC4FDE-DC1C-4A6E-A98A-89E4D71B2380Q34267838-77F6A1CC-8AE3-46DE-98BC-A0DAE32C02B2Q34269067-59C87623-F429-477F-8CCF-CC93AFE7E58BQ34528945-46F9CED4-D849-4013-A415-6FECF7CCB086Q34682886-A2B33DB6-EF21-40BC-9C3D-98756BF296B0Q34732855-D592BC86-E7E8-4D14-ADD3-CACFA01E70F7Q34982469-9C4C0EF5-2515-4AF0-A863-2A851182B32CQ35078472-5E4A6ABC-879D-493E-9568-32561F87CAB3Q35915261-C90DA67A-DB9B-4F4E-8C7A-F7FDCD032DB6Q35929914-3BC15154-6185-4533-9F8C-5A22C3B38EFCQ36180493-6369830D-D601-42CA-B597-7F94594E2AB6Q36232419-1DC94896-0EDE-4E92-9485-672ED53BC17EQ36237983-2C3E9F1A-C5BB-448E-8D8A-6D26A18C8A86Q36567746-B74C2B43-C716-4C1C-B815-136FA9ED5670Q37679768-938124E9-CFE5-4CFA-B20C-B7BE06974068Q37679780-FE1F1A4F-EA77-4F3B-979D-0AECB35AE885Q37980031-AFBE68E9-E22B-4415-A1BB-229C219F9C29Q38404398-31C271AC-3B0B-4EFE-B846-7B666236419BQ38447697-6315ED6C-09AB-41ED-BE22-F90E7FD53468Q38634643-0D522662-EA9D-43C5-86B1-19922025AE06Q41345150-24FA9AA8-F8D2-4F1B-984A-BA45610F718AQ47960948-0543F554-E265-4675-9B5F-7888C6D5CA31Q52597956-0DB1E865-BE98-4B1C-B4E6-F5E5F1BEC9FDQ52768051-E5B13DBA-665E-4DCB-9926-0D0176D29FAFQ58616174-5C0C40E6-70AB-4EB4-AB16-CF255ABD8940Q58755827-63B886FD-2AAB-43FF-A59C-BEEDD0DC9AF2
P2860
Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pulmonary nontuberculous mycob ...... treatment and associated costs
@en
Pulmonary nontuberculous mycob ...... reatment and associated costs.
@nl
type
label
Pulmonary nontuberculous mycob ...... treatment and associated costs
@en
Pulmonary nontuberculous mycob ...... reatment and associated costs.
@nl
prefLabel
Pulmonary nontuberculous mycob ...... treatment and associated costs
@en
Pulmonary nontuberculous mycob ...... reatment and associated costs.
@nl
P2093
P2860
P1433
P1476
Pulmonary nontuberculous mycob ...... treatment and associated costs
@en
P2093
D Rebecca Prevots
Guillermo J Ballarino
Kenneth N Olivier
Reginald J Claypool
Steven M Holland
P2860
P304
P356
10.1016/J.RMED.2009.04.026
P577
2009-05-21T00:00:00Z